The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Epidermal Necrolysis, Toxic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Epidermal Necrolysis, Toxic


High impact information on Epidermal Necrolysis, Toxic


Chemical compound and disease context of Epidermal Necrolysis, Toxic


Biological context of Epidermal Necrolysis, Toxic


Anatomical context of Epidermal Necrolysis, Toxic


Gene context of Epidermal Necrolysis, Toxic


Analytical, diagnostic and therapeutic context of Epidermal Necrolysis, Toxic


  1. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. Roujeau, J.C., Kelly, J.P., Naldi, L., Rzany, B., Stern, R.S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F. N. Engl. J. Med. (1995) [Pubmed]
  2. Desensitization for sulfasalazine skin rash. Purdy, B.H., Philips, D.M., Summers, R.W. Ann. Intern. Med. (1984) [Pubmed]
  3. Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy. Knowles, S., Shapiro, L., Shear, N.H. Drug safety : an international journal of medical toxicology and drug experience. (2001) [Pubmed]
  4. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. John, T., Foulks, G.N., John, M.E., Cheng, K., Hu, D. Ophthalmology (2002) [Pubmed]
  5. Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital. Duncan, K.O., Tigelaar, R.E., Bolognia, J.L. J. Am. Acad. Dermatol. (1999) [Pubmed]
  6. Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma. Rajkumar, S.V., Gertz, M.A., Witzig, T.E. N. Engl. J. Med. (2000) [Pubmed]
  7. Toxic epidermal necrolysis after mithramycin. Purpora, D., Ahern, M.J., Silverman, N. N. Engl. J. Med. (1978) [Pubmed]
  8. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.H., Tschopp, J., French, L.E. Science (1998) [Pubmed]
  9. Toxic epidermal necrolysis from atorvastatin. Pfeiffer, C.M., Kazenoff, S., Rothberg, H.D. JAMA (1998) [Pubmed]
  10. Toxic epidermal necrolysis associated with maternal use of heparin. Leung, A. JAMA (1985) [Pubmed]
  11. Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome. Levitt, L., Pearson, R.W. JAMA (1980) [Pubmed]
  12. Hyperosmolality induced by propylene glycol. A complication of silver sulfadiazine therapy. Fligner, C.L., Jack, R., Twiggs, G.A., Raisys, V.A. JAMA (1985) [Pubmed]
  13. Lamotrigine and toxic epidermal necrolysis. Sachs, B., Rönnau, A.C., Ruzicka, T., Gleichmann, E., Schuppe, H.C. Lancet (1996) [Pubmed]
  14. Possible association between toxic epidermal necrolysis and ciprofloxacin. Tham, T.C., Allen, G., Hayes, D., McGrady, B., Riddell, J.G. Lancet (1991) [Pubmed]
  15. Co-trimoxazole for toxic epidermal necrolysis in AIDS. Senneville, E., Lecocq, P., Ajana, F., Chidiac, C., Mouton, Y. Lancet (1991) [Pubmed]
  16. Kinetics and specificity of fas ligand induction in toxic epidermal necrolysis. Chang, H.Y., Cooper, Z.A., Swetter, S.M., Marinkovich, M.P. Archives of dermatology. (2004) [Pubmed]
  17. Apoptotic cell death in toxic epidermal necrolysis: the Fas ligand assumption. Gravante, G., Esposito, G., Filingeri, V., Delogu, D., Castrì, F., Montone, A. Arch. Dermatol. Res. (2006) [Pubmed]
  18. Lyell's syndrome: histological, immunohistochemical and serological observations. Babala, J., Brozman, M., Blazovsky, J. Acta paediatrica Academiae Scientiarum Hungaricae. (1976) [Pubmed]
  19. Toxic epidermal necrolysis associated with treatment for preterm labor. Claessens, N., Delbeke, L., Lambert, J., Matthieu, L., Lafaire, C., Van Marck, E. Dermatology (Basel) (1998) [Pubmed]
  20. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. Tapia, B., Padial, A., Sánchez-Sabaté, E., Alvarez-Ferreira, J., Morel, E., Blanca, M., Bellón, T. J. Allergy Clin. Immunol. (2004) [Pubmed]
  21. Numerical, morphological and phenotypic changes in Langerhans cells in the course of murine graft-versus-host disease. Asagoe, K., Takahashi, K., Yoshino, T., Kondo, E., Tanaka, R., Arata, J., Akagi, T. Br. J. Dermatol. (2001) [Pubmed]
  22. Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients. McDonald, B.J., Singer, J.W., Bianco, J.A. The Annals of pharmacotherapy. (1992) [Pubmed]
  23. Erythema multiforme and toxic epidermal necrolysis: a comparative study. Paquet, P., Piérard, G.E. The American Journal of dermatopathology. (1997) [Pubmed]
  24. Captopril-induced toxic epidermal necrolysis and agranulocytosis successfully treated with granulocyte colony-stimulating factor. Winfred, R.I., Nanda, S., Horvath, G., Elnicki, M. South. Med. J. (1999) [Pubmed]
  25. Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis. Correia, O., Delgado, L., Barbosa, I.L., Campilho, F., Fleming-Torrinha, J. J. Am. Acad. Dermatol. (2002) [Pubmed]
  26. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. Nassif, A., Moslehi, H., Le Gouvello, S., Bagot, M., Lyonnet, L., Michel, L., Boumsell, L., Bensussan, A., Roujeau, J.C. J. Invest. Dermatol. (2004) [Pubmed]
  27. Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes. Schmidt, E., Wehr, B., Tabengwa, E.M., Reimer, S., Bröcker, E.B., Zillikens, D. Clin. Exp. Immunol. (2004) [Pubmed]
  28. Studies of the mechanism of epidermal injury by a Staphylococcal epidermolytic toxin. Wuepper, K.D., Dimond, R.L., Knutson, D.D. J. Invest. Dermatol. (1975) [Pubmed]
  29. Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis. Tagami, H., Tatsuta, K., Iwatski, K., Yamada, M. Archives of dermatology. (1983) [Pubmed]
  30. Dermatologic side effects of thalidomide in patients with multiple myeloma. Hall, V.C., El-Azhary, R.A., Bouwhuis, S., Rajkumar, S.V. J. Am. Acad. Dermatol. (2003) [Pubmed]
  31. Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine. Sommers, K.R., Kong, K.M., Bui, D.T., Fruehauf, J.P., Holcombe, R.F. Anticancer Drugs (2003) [Pubmed]
  32. Toxic epidermal necrolysis after treatment with lamotrigine (Lamictal). Fogh, K., Mai, J. Seizure : the journal of the British Epilepsy Association. (1997) [Pubmed]
  33. Management of cutaneous drug reactions. Babu, K.S., Belgi, G. Current allergy and asthma reports. (2002) [Pubmed]
WikiGenes - Universities